Report: Calif. stem cell agency needs overhaul

Published



LOS ANGELES (AP) — California has transformed into a major player in stem cell research, but the taxpayer-funded institute responsible has “significant deficiencies” in how research dollars are distributed, experts said Thursday.

A report by the Institute of Medicine found too many members on the board of the California Institute for Regenerative Medicine represented schools that won funding and recommended a restructuring to avoid the appearance of conflict of interest.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.